Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.54B |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$6.22B |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$6.12B |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$5.39B |
| 5 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$367M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
Diageo
DEO
|
+$297M |
| 4 |
Medtronic
MDT
|
+$259M |
| 5 |
GE Aerospace
GE
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.36% |
| 2 | Financials | 10.66% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
argenx
ARGX
$53.7B
| $1.16M | ﹤0.01% |
2,691
+565
| +27% | +$216K |
|
2877
Northeast Bank
NBN
$1.06B
| $1.16M | ﹤0.01% |
18,983
+775
| +4% | +$42.7K |
|
2878
Oric Pharmaceuticals
ORIC
$1.16B
| $1.15M | ﹤0.01% |
162,366
+57,822
| +55% | +$518K |
|
|
MCBC
2879
DELISTED
Macatawa Bank Corp
MCBC
| $1.15M | ﹤0.01% |
78,492
+7,550
| +11% | +$101K |
|
2880
GCM Grosvenor
GCMG
$751M
| $1.14M | ﹤0.01% |
117,270
+2,965
| +3% | +$28.6K |
|
|
GOEV
2881
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $1.14M | ﹤0.01% |
26,831
+14,397
| +116% | +$705K |
|
2882
Equinor
EQNR
$97.5B
| $1.14M | ﹤0.01% |
39,872
+16,708
| +72% | +$466K |
|
2883
Tiptree Inc
TIPT
$657M
| $1.14M | ﹤0.01% |
68,984
+5,999
| +10% | +$100K |
|
2884
Outset Medical
OM
$85.8M
| $1.14M | ﹤0.01% |
19,681
-7,229
| -27% | -$354K |
|
2885
Gossamer Bio
GOSS
$81.6M
| $1.14M | ﹤0.01% |
1,261,597
+8,833
| +0.7% | +$6.61K |
|
|
ATXS
2886
DELISTED
Astria Therapeutics
ATXS
| $1.13M | ﹤0.01% |
124,538
-6,531
| -5% | -$63.8K |
|
2887
Vanguard Financials ETF
VFH
$13.5B
| $1.13M | ﹤0.01% |
11,295
-5,205
| -32% | -$520K |
|
2888
Ero Copper
ERO
$2.81B
| – | – |
0
| – | – |
|
2889
Nature's Sunshine
NATR
$354M
| $1.13M | ﹤0.01% |
74,692
+1,932
| +3% | +$33K |
|
2890
Zymeworks
ZYME
$1.62B
| $1.12M | ﹤0.01% |
132,148
+6,657
| +5% | +$59.3K |
|
2891
Marcus Corp
MCS
$867M
| $1.12M | ﹤0.01% |
98,370
+22,747
| +30% | +$270K |
|
2892
Consolidated Water Co
CWCO
$469M
| $1.12M | ﹤0.01% |
42,016
+1,606
| +4% | +$42K |
|
2893
Annexon
ANNX
$837M
| $1.12M | ﹤0.01% |
227,560
+46,509
| +26% | +$241K |
|
2894
Innodata
INOD
$2.07B
| $1.11M | ﹤0.01% |
75,111
+3,362
| +5% | +$34.9K |
|
2895
Celcuity
CELC
$4.24B
| $1.11M | ﹤0.01% |
67,959
+22,646
| +50% | +$379K |
|
2896
Capital City Bank Group
CCBG
$889M
| $1.11M | ﹤0.01% |
39,106
+3,891
| +11% | +$106K |
|
2897
Peoples Financial Services
PFIS
$702M
| $1.11M | ﹤0.01% |
24,416
+6,425
| +36% | +$252K |
|
|
BLDP
2898
Ballard Power Systems
BLDP
$829M
| $1.11M | ﹤0.01% |
+492,091
| New | +$1.4M |
|
2899
Vodafone
VOD
$36.4B
| $1.11M | ﹤0.01% |
125,196
+55,281
| +79% | +$493K |
|
2900
Traeger
COOK
$173M
| $1.11M | ﹤0.01% |
9,240
+52
| +0.6% | +$6.01K |
|
Similar funds
Charles Schwab's Q2 2024 Portfolio in Review
As of Q2 2024, Charles Schwab held 3,738 positions worth $525B, up 21% from $433B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab deployed $84.3B of net new capital in Q2 2024, opening 263 new positions and adding to 2,391 existing holdings. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Texas Instruments, an estimated $367M trimmed.
- Charles Schwab's largest Q2 2024 buy was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
- Charles Schwab added most to Schwab Fundamental US Large Company Index ETF in Q2 2024, an estimated $8.54B increase.
- Charles Schwab's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $367M.
- Charles Schwab fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $335M.
- Charles Schwab's ten largest holdings make up 21% of its $525B portfolio in Q2 2024.
- Charles Schwab opened 263 new positions and closed 116 in Q2 2024.
- Charles Schwab's portfolio value rose 21% quarter-over-quarter to $525B.
Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.